Loading chat...

WV HB4640

Bill

Status

Introduced

1/21/2026

Primary Sponsor

Evan Worrell

Click for details

Origin

House of Delegates

2026 Regular Session

AI Summary

  • Amends West Virginia Code §60A-2-204 to modify Schedule I drug classifications related to psilocybin substances
  • Creates an exception for organic psilocybin or crystalline polymorph psilocybin that receives approval from both the Food and Drug Administration and the Drug Enforcement Administration
  • Maintains psilocybin and psilocyn on the Schedule I controlled substances list under hallucinogenic substances
  • Introduced January 21, 2026, by Delegates Worrell and Hite and referred to the Committee on Health and Human Resources
  • Reenacts the comprehensive Schedule I drug list including opiates, opium derivatives, hallucinogens, synthetic cannabinoids, depressants, and stimulants with their chemical names and structures

Legislative Description

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Health

Last Action

On 1st reading, House Calendar

2/2/2026

Committee Referrals

Health & Human Resources1/21/2026

Full Bill Text

No bill text available